New Antibiotics for Resistant Infections: What Happens After Approval?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Antibiotics for Resistant Infections: What Happens After Approval?

Published:2024-05 Issue:5 Volume:177 Page:674-675
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Howard-Anderson Jessica¹,Boucher Helen W.²

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

2. Tufts University School of Medicine and Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts

Publisher

American College of Physicians

Link

https://www.acpjournals.org/doi/pdf/10.7326/M24-0192

Reference7 articles.

1. A new class of antibiotics is cause for cautious celebration — but the economics must be fixed

2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

3. Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals

4. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

5. Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3